Febril neutropeni hur agera - PowerPoint PPT Presentation

1 / 21
About This Presentation
Title:

Febril neutropeni hur agera

Description:

oesophagus and in the perianal region. Mucositis severely ... Vid septisk chock efterstr var man snabb baktericid effekt % survival. AG top level 7/28 ... – PowerPoint PPT presentation

Number of Views:72
Avg rating:3.0/5.0
Slides: 22
Provided by: mats192
Category:

less

Transcript and Presenter's Notes

Title: Febril neutropeni hur agera


1
Febril neutropeni- hur agera?
  • Mats Kalin
  • Department of Medicine
  • Infectious Disease Unit
  • Karolinska Universitetssjukhuset, Solna
  • mats.kalin_at_karolinska.se

2
Non-specific defense
Cytoreductive chemotherapy will affect all
cells with a high rate of division, like
bone marrow cells and epithelial
cells, especially those in the GI tract
First line of defense Barrier function
skin
Second line of defense
CTL
P
B
T
Granulocytes
Macrophages
3
Mucous membranes are affected causing mucositis,
which may be especially severe in the oral
cavity, in the lower oesophagus and in the
perianal region. Mucositis severely compromises
the barrier function Therefore,
translocation of bacteria from the entire GI
tract to the blood is increased
Non-specific defense
First line of defense Barrier function
4
Bacteria translocated to the blood stream are
normally rapidly cleared by granulocytes In
case of granulocytopenia bacteremia with signs
and symptoms of sepsis will develop
Non-specific defense
First line of defense Barrier function
Second line of defense
Granulocytes
Macrophages
5
Infection Risk in Relation to Granulocyte Count
100
W I T H F E V E R
H
lt1000
B
90
lt500
J
80
H
lt100
H
70
60
H
50
40
30
H
J
20
J
J
10
J
H
B
J
B
B
B
B
B
J
H
0
5 10
days
Bodey et al 1969
6
In addition to mucositis and granulocytopenia
cancer chemotherapy will cause - T and B cell
deficiencies - for long time periods implying
increased risks for infection w - intracellular
bacteria, herpes viruses, PCP and other fungi
(T-deficiency) - pneumococci (Ig-deficiency)
CTL
P
Antigen presentation
Cytokine regulation
B
T
Granulocytes
Macrophages
In addition steroids and other drugs may
compromise macrophage function
7
  • Translocated bacteria
  • causing bacteremia
  • in neutropenic patients are
  • Gramneg enteric rods
  • from the lower GI tract
  • including P.aeruginosa
  • alpha-streptococci
  • from the oral cavity
  • S.aureus

8
Blood stream Pathogens at the Center for
Haematology, Karolinska hospital 1988-2001
n1402
Other Gramneg
Stenotrophomonas maltophilia
The distribution of bacteria isolated in blood
cultures are similar in children at the oncology
unit ALB, Karolinska
Enterobacter
CNS
Pseudomonas aerugionsa
S.aureus
Klebsiella
Alpha-strept
E.coli
Enterococci
Cherif et al 2004 The Haematology J 4240
Pneumococci
Other Grampos
9
Course in Neutropenic Patients with Pseudomonas
Bacteremia who did not Receive Appropriate Therapy
Bodey et al 1985, Arch Intern Med 1451621
10
Infections in Neutropenic Cancer Patients
  • The risk for bacterial infection is related to
    the depth and length of neutropenia
  • Bacteria are translocated from the GI tract
  • The GI flora may be affected by
    hospitalization and ab therapy
  • The course may be fulminant with septic shock
  • Symptoms may be subtle due to lack of immune
    response
  • Fever is the signal for risk of serious
    infection
  • Broad-spectrum antibiotic therapy must be started
  • immediately when a patient presents with fever
    with
  • Cephalosporin with Pseudomonas activity or
  • Carbapenem or
  • Piperacillin/Tazobactam

11
Betalaktamantibiotika - koncentrations-o-beroende
avdödning liksom flertalet andra
antibiotika Aminoglykosider - snabb baktericid
effekt - koncentrations-beroende
avdödning liksom kinoloner och några andra prep
Bakterie-konc cfu / ml
105
Betalaktamantibiotikum 4 x MIC
Betalaktamantibiotikum 10 x MIC
Aminoglykosid 10 x MIC
Aminoglykosid 4 x MIC
24 H
Vid septisk chock eftersträvar man snabb
baktericid effekt
12
Aminoglykosider
  • Mycket snabb baktericid effekt
  • Ökar trol chansen för överlevnad vid svår sepsis
  • men nefrotox kan vara svårhanterat
  • Doseras för maximal effekt
  • en gång per dygn
  • Endosering ger något lägre toxicitet
  • Vid endosering bör dalvärdet vara nära 0
  • Toppvärdet har ingen betydelse för tox, men ett
    bra toppvärde är pos korrelerat till överlevnad
    vid svår sepsis

survival
AG top level gt 7/28 vs lt 7/28 mg/L Moore 1984,
Am J Med 77756
13
  • CNS has become the most common
  • etiology in neutropenic fever
  • - due to the frequent use of CVCs
  • - CNS are usually multiresistant, but
  • - the course is most often not fulminant
  • - CNS therefore not covered from start
  • Focal symptoms may be missing
  • Also enterococci are isolated with increasing
    frequency
  • Addition of Vancomycin is the most common
    modification in neutropenic fever not responding
    to the initial regimen
  • seems to be well gounded
  • nb, if the patient has continued fever and is
    not improving when continued therapy with started
    regimen is recommended

14
It is of decisive importance to follow the
course closely
Therapy may have to be changed as a results of
deteriorating general condition new signs
and symptoms of focal infection results of
cultures, most importantly blood cultures
results of chest X ray or other investigations
15
Cherif 2004, SJID 36593
16
Neutropenic Children with Cancer Chemother
  • Patients not suitable for outpt ther
  • Leukemia induction therapy
  • BMT
  • Clin unstable
  • Hypotension
  • Respiratory distress
  • Haemorrhage
  • Soft tissue infection
  • Pneumonia
  • Sever mucositis
  • Socially unstable
  • Death rate 1
  • ICU admittance 1
  • Average no of fever days 3
  • Neutropenia 4-5 d after fever
  • Bacteremia 15-20
  • Low-risk patients identifiable w very low risk
    of bacteremia or death. Hospital readmittance
    4-22 in 8 studies (494 pts)
  • Therapy with ceftriaxone, genta/cloxa/ticar, po
    quinolone OK
  • Mullen 2001 Brit J Haematol 112832
  • Oral Cefixime vs Ticar/Amika/Vanco 28 vs 27
    failure, no death
  • Shenep 2001 CID 3236

17
Invasive Candidiasis
  • Incidence probably ?
  • Diagnosis difficult
  • Clin pres nonspecific
  • Blood cult often neg
  • Skin lesions uncommon - biopsy for micro and
    culture if present

  • Retinal infiltrates specific, very uncommon due
    to neutropenia
  • Empiric therapy used, but unclear indications,
    when to start, when to stop and total benefit


18
Empiric AmB O.6 mg/kg / day after 4 d of
neutropenic fever
19
In Vitro Susceptibility of Fungal Species
20
Viral infections in neutropenic hosts
  • T-cells decisive for defense
    against viruses w a latent
    phase
  • Herpes simplex reactivation common cause of
    fever
  • VZV reactivation rather common, may be severe
  • CMV reactivation less common. Very important in
    allo-BMT PCR diagnosis and preemptive therapy
    for control. In other hosts occasionally fever,
    colitis, hepatitis, but most often reactivation
    of unknown significance.
  • Adenovirus may also be latent. Occasional severe
    cases
  • Influenza, RSV, parainfluenza may cause severe
    pneumonia

21
Causes of fever in cancer patients
Bacterial translocation from GI tract Focal
bacterial infections including CVC-related
infection Mycobacterial infection Fungal
infection, Yeast, Mold, PCP Viral infection
Bleeding / haematoma Tromboembolic events Tumor
related fever Drug fever
Write a Comment
User Comments (0)
About PowerShow.com